Literature DB >> 33643322

Mechanisms of Antibiotic Failure During Staphylococcus aureus Osteomyelitis.

Brittney D Gimza1, James E Cassat1,2,3,4,5.   

Abstract

Staphylococcus aureus is a highly successful Gram-positive pathogen capable of causing both superficial and invasive, life-threatening diseases. Of the invasive disease manifestations, osteomyelitis or infection of bone, is one of the most prevalent, with S. aureus serving as the most common etiologic agent. Treatment of osteomyelitis is arduous, and is made more difficult by the widespread emergence of antimicrobial resistant strains, the capacity of staphylococci to exhibit tolerance to antibiotics despite originating from a genetically susceptible background, and the significant bone remodeling and destruction that accompanies infection. As a result, there is a need for a better understanding of the factors that lead to antibiotic failure in invasive staphylococcal infections such as osteomyelitis. In this review article, we discuss the different non-resistance mechanisms of antibiotic failure in S. aureus. We focus on how bacterial niche and destructive tissue remodeling impact antibiotic efficacy, the significance of biofilm formation in promoting antibiotic tolerance and persister cell formation, metabolically quiescent small colony variants (SCVs), and potential antibiotic-protected reservoirs within the substructure of bone.
Copyright © 2021 Gimza and Cassat.

Entities:  

Keywords:  SCVs; Staphylococcus aureus; antibiotic failure; antibiotic tolerance; biofilm; intracellular survival; osteomyelitis; persisters

Year:  2021        PMID: 33643322      PMCID: PMC7907425          DOI: 10.3389/fimmu.2021.638085

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  89 in total

Review 1.  Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus.

Authors:  Timothy J Foster; Joan A Geoghegan; Vannakambadi K Ganesh; Magnus Höök
Journal:  Nat Rev Microbiol       Date:  2014-01       Impact factor: 60.633

Review 2.  Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.

Authors:  Barbara C Kahl; Karsten Becker; Bettina Löffler
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 3.  Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis.

Authors:  Gowrishankar Muthukrishnan; Elysia A Masters; John L Daiss; Edward M Schwarz
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

4.  Persister formation in Staphylococcus aureus is associated with ATP depletion.

Authors:  Brian P Conlon; Sarah E Rowe; Autumn Brown Gandt; Austin S Nuxoll; Niles P Donegan; Eliza A Zalis; Geremy Clair; Joshua N Adkins; Ambrose L Cheung; Kim Lewis
Journal:  Nat Microbiol       Date:  2016-04-18       Impact factor: 17.745

5.  A novel mouse model of Staphylococcus aureus chronic osteomyelitis that closely mimics the human infection: an integrated view of disease pathogenesis.

Authors:  Sarah A Horst; Verena Hoerr; Andreas Beineke; Carolin Kreis; Lorena Tuchscherr; Julia Kalinka; Sabine Lehne; Ina Schleicher; Gabriele Köhler; Thomas Fuchs; Michael J Raschke; Manfred Rohde; Georg Peters; Cornelius Faber; Bettina Löffler; Eva Medina
Journal:  Am J Pathol       Date:  2012-08-16       Impact factor: 4.307

6.  Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study.

Authors:  Rachna Singh; Pallab Ray; Anindita Das; Meera Sharma
Journal:  J Med Microbiol       Date:  2009-06-15       Impact factor: 2.472

7.  MyD88 and IL-1R signaling drive antibacterial immunity and osteoclast-driven bone loss during Staphylococcus aureus osteomyelitis.

Authors:  Nicole E Putnam; Laura E Fulbright; Jacob M Curry; Caleb A Ford; Jenna R Petronglo; Andrew S Hendrix; James E Cassat
Journal:  PLoS Pathog       Date:  2019-04-12       Impact factor: 6.823

8.  Intracellular Staphylococcus aureus persisters upon antibiotic exposure.

Authors:  Frédéric Peyrusson; Hugo Varet; Tiep Khac Nguyen; Rachel Legendre; Odile Sismeiro; Jean-Yves Coppée; Christiane Wolz; Tanel Tenson; Françoise Van Bambeke
Journal:  Nat Commun       Date:  2020-05-04       Impact factor: 14.919

9.  Triple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureus.

Authors:  Stephen C Becker; Dwayne R Roach; Vinita S Chauhan; Yang Shen; Juli Foster-Frey; Anne M Powell; Gary Bauchan; Richard A Lease; Homan Mohammadi; William J Harty; Chad Simmons; Mathias Schmelcher; Mary Camp; Shengli Dong; John R Baker; Tamsin R Sheen; Kelly S Doran; David G Pritchard; Raul A Almeida; Daniel C Nelson; Ian Marriott; Jean C Lee; David M Donovan
Journal:  Sci Rep       Date:  2016-04-28       Impact factor: 4.379

Review 10.  Control of Phagocytosis by Microbial Pathogens.

Authors:  Eileen Uribe-Querol; Carlos Rosales
Journal:  Front Immunol       Date:  2017-10-24       Impact factor: 7.561

View more
  9 in total

1.  Linearized teixobactin is inactive and after sequence enhancement, kills methicillin-resistant Staphylococcus aureus via a different mechanism.

Authors:  Qianhui Wu; Biswajit Mishra; Guangshun Wang
Journal:  Pept Sci (Hoboken)       Date:  2022-04-25

2.  A self-assembled bilayer polypeptide-engineered hydrogel for spatiotemporal modulation of bactericidal and anti-inflammation process in osteomyelitis treatment.

Authors:  Xiaoting Xie; Jiemao Wei; Bin Zhang; Wei Xiong; Zhiyi He; Yayun Zhang; Chenghao Gao; Yuandi Zhao; Bo Liu
Journal:  J Nanobiotechnology       Date:  2022-09-15       Impact factor: 9.429

3.  Substance P Exacerbates the Inflammatory and Pro-osteoclastogenic Responses of Murine Osteoclasts and Osteoblasts to Staphylococcus aureus.

Authors:  M Brittany Johnson; Samantha R Suptela; Sophie E Sipprell; Ian Marriott
Journal:  Inflammation       Date:  2022-08-30       Impact factor: 4.657

4.  Halicin Is Effective Against Staphylococcus aureus Biofilms In Vitro.

Authors:  Shota Higashihira; Stefanie Jan Simpson; Christopher David Collier; Roman Michael Natoli; Mizuho Kittaka; Edward Michael Greenfield
Journal:  Clin Orthop Relat Res       Date:  2022-05-17       Impact factor: 4.755

Review 5.  Staphylococcus aureus infections in children.

Authors:  James E Cassat; Isaac Thomsen
Journal:  Curr Opin Infect Dis       Date:  2021-10-01       Impact factor: 4.968

6.  Metatranscriptome sequencing identifies Escherichia are major contributors to pathogenic functions and biofilm formation in diabetes related foot osteomyelitis.

Authors:  Michael Radzieta; Matthew Malone; Mehtab Ahmad; Hugh G Dickson; Saskia Schwarzer; Slade O Jensen; Lawrence A Lavery
Journal:  Front Microbiol       Date:  2022-08-01       Impact factor: 6.064

7.  Treatment of Periprosthetic Joint Infection and Fracture-Related Infection With a Temporary Arthrodesis Made by PMMA-Coated Intramedullary Nails - Evaluation of Technique and Quality of Life in Implant-Free Interval.

Authors:  Nike Walter; Susanne Baertl; Siegmund Lang; Dominik Szymski; Johannes Weber; Volker Alt; Markus Rupp
Journal:  Front Surg       Date:  2022-09-02

Review 8.  Nanotechnology in the Diagnosis and Treatment of Osteomyelitis.

Authors:  Demi Zapata; Jordan Higgs; Hunter Wittholt; Kishore Chittimalli; Amanda E Brooks; Pranothi Mulinti
Journal:  Pharmaceutics       Date:  2022-07-27       Impact factor: 6.525

9.  Controlled Release Mechanism of Vancomycin from Double-Layer Poly-L-Lactic Acid-Coated Implants for Prevention of Bacterial Infection.

Authors:  Papon Thamvasupong; Kwanchanok Viravaidya-Pasuwat
Journal:  Polymers (Basel)       Date:  2022-08-26       Impact factor: 4.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.